Scarica l'app Stockscreener
9.03
1.46%
0.13
Dopo l'orario di chiusura:
9.03
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FOLD Giù?
Forum
Previsione
Precedente Chiudi:
$8.90
Aprire:
$8.9
Volume 24 ore:
4.89M
Relative Volume:
1.02
Capitalizzazione di mercato:
$2.78B
Reddito:
$571.16M
Utile/perdita netta:
$-38.10M
Rapporto P/E:
-73.71
EPS:
-0.1225
Flusso di cassa netto:
$-48.91M
1 W Prestazione:
+4.15%
1M Prestazione:
+14.59%
6M Prestazione:
+17.58%
1 anno Prestazione:
-20.93%
Intervallo 1D:
$8.7532
$9.17
Intervallo di 1 settimana:
$8.63
$9.285
Portata 52W:
$5.51
$12.65
Amicus Therapeutics Inc Stock (FOLD) Company Profile
Nome
Amicus Therapeutics Inc
Settore
Industria
Telefono
(609) 662-2000
Indirizzo
47 HULFISH STREET, PRINCETON, NJ
Confronta FOLD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FOLD
Amicus Therapeutics Inc
|
9.03 | 2.74B | 571.16M | -38.10M | -48.91M | -0.1225 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Aggiornamento | Needham | Hold → Buy |
| 2025-07-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-09-06 | Iniziato | Jefferies | Buy |
| 2024-05-30 | Iniziato | Wells Fargo | Overweight |
| 2024-05-14 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-12-19 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Ripresa | Goldman | Neutral |
| 2022-01-14 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-15 | Aggiornamento | Stifel | Hold → Buy |
| 2021-09-30 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-07-19 | Ripresa | BTIG Research | Buy |
| 2021-05-27 | Iniziato | Needham | Hold |
| 2021-05-21 | Iniziato | UBS | Buy |
| 2021-04-14 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-03-02 | Iniziato | Stifel | Hold |
| 2021-02-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-12-28 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-12-10 | Downgrade | Citigroup | Buy → Neutral |
| 2020-11-11 | Iniziato | Berenberg | Hold |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-02-04 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-11-12 | Reiterato | H.C. Wainwright | Buy |
| 2019-06-17 | Iniziato | H.C. Wainwright | Buy |
| 2019-06-05 | Reiterato | Cantor Fitzgerald | Overweight |
| 2019-04-05 | Iniziato | Janney | Buy |
| 2019-01-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-10-29 | Iniziato | Citigroup | Neutral |
| 2018-08-17 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2017-10-06 | Ripresa | Goldman | Neutral |
| 2017-09-13 | Reiterato | Chardan Capital Markets | Buy |
| 2017-08-10 | Reiterato | Chardan Capital Markets | Buy |
| 2017-01-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2016-05-18 | Iniziato | BofA/Merrill | Buy |
| 2016-04-14 | Iniziato | Robert W. Baird | Neutral |
| 2016-04-12 | Reiterato | Chardan Capital Markets | Buy |
| 2015-09-16 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2015-06-16 | Reiterato | Chardan Capital Markets | Buy |
Mostra tutto
Amicus Therapeutics Inc Borsa (FOLD) Ultime notizie
Using data models to predict Amicus Therapeutics Inc. stock movementShort Setup & Daily Technical Forecast Reports - newser.com
Is Amicus Therapeutics Inc. meeting your algorithmic filter criteria2025 Support & Resistance & Weekly Momentum Picks - newser.com
Is Amicus Therapeutics Inc. (AM6) stock undervalued at current price2025 Market Outlook & Capital Efficient Trade Techniques - newser.com
Understanding Amicus Therapeutics Inc.’s price movementRate Hike & AI Enhanced Trading Alerts - newser.com
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025 - GlobeNewswire
Using RSI to spot recovery in Amicus Therapeutics Inc.Market Risk Analysis & Risk Controlled Swing Alerts - newser.com
Visual trend scoring systems applied to Amicus Therapeutics Inc.Weekly Gains Report & Weekly Setup with High ROI Potential - newser.com
Is Amicus Therapeutics Inc. stock near bottom after decline2025 Breakouts & Breakdowns & High Accuracy Swing Trade Signals - newser.com
Is Amicus Therapeutics Inc. (AM6) stock trading at attractive multiplesEarnings Summary Report & AI Driven Price Predictions - newser.com
Why Amicus Therapeutics Inc. stock is a must watch in 2025Portfolio Update Summary & Safe Capital Growth Tips - newser.com
Can Amicus Therapeutics Inc. stock maintain growth trajectoryEarnings Growth Summary & Technical Buy Zone Confirmations - newser.com
Amicus (Nasdaq: FOLD) to present at UBS and Jefferies investor conferences in Nov 2025 - Stock Titan
What earnings revisions data tells us about Amicus Therapeutics Inc.Trade Risk Summary & Technical Pattern Based Signals - newser.com
What RSI levels show for Amicus Therapeutics Inc. (AM6) stockQuarterly Portfolio Report & Growth Focused Entry Reports - newser.com
How interest rate cuts could boost Amicus Therapeutics Inc. stockEntry Point & Real-Time Market Trend Scan - newser.com
How Amicus Therapeutics Inc. (AM6) stock performs during market turbulenceWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
Amicus Therapeutics Inc. stock chart pattern explainedWeekly Profit Report & Fast Moving Market Watchlists - newser.com
Is Amicus Therapeutics Inc AM6 a good long term investmentInsider Selling Patterns & Interactive Charts for Smarter Trading - earlytimes.in
Published on: 2025-10-31 00:48:13 - newser.com
Chart based exit strategy for Amicus Therapeutics Inc.Gap Down & Detailed Earnings Play Alerts - newser.com
Amicus Therapeutics (FOLD) to Release Earnings on Tuesday - MarketBeat
Amicus Therapeutics Inc AM6 Stock Analysis and ForecastFinancial Sector Performance & Affordable Investment Portfolio - earlytimes.in
How Amicus Therapeutics Inc. (AM6) stock moves in volatile trading sessionsTrade Analysis Summary & Free Technical Pattern Based Buy Signals - newser.com
LATAM Fabry Disease Market See Incredible Growth 2025-2032 | - openPR.com
AlphaQuest LLC Has $465,000 Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Y Intercept Hong Kong Ltd Boosts Stock Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Peregrine Capital Management LLC Raises Stock Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics Inc Azioni (FOLD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):